Table 1.
Patient characteristics at time of reconstruction.
| Patient characteristic | Value | |
|---|---|---|
| Sample size; n | 101 | |
| Age; mean ± SD (years) | 49.1 | ±10.4 |
| BMI; mean ± SD (kg/m2) | 26.65 | ±2.41 |
| Laterality; n (%) | ||
| Unilateral | 57 | (56.4%) |
| Bilateral | 44a | (43.5%) |
| Smoking status; n (%) | ||
| Nonsmoker | 58 | (57.4%) |
| Ex-smoker | 40 | (39.6%) |
| Current smokerb | 3 | (3.0%) |
| Systemic (neo)adjuvant treatment; n (%) | ||
| No systemic (neo)adjuvant treatment | 33 | (32.6%) |
| Chemotherapy only | 15 | (14.9%) |
| Hormonal therapy only | 3 | (3.0%) |
| Chemotherapy and hormonal therapy | 50 | (49.5%) |
| High-risk genetic mutation; n (%) | ||
| High-risk mutationc | 28 | (27.7%) |
| No mutation | 25 | (24.8%) |
| Unknown (not tested) | 47 | (46.5%) |
a
In 9 patients, one of two reconstructed breasts is excluded.
b
Defined as actively smoking at the time of, quitting smoking <3 months prior to and/or restarting smoking after reconstruction.
c
BRCA1, BRCA2 and CHEK2 mutation.